Ratings BBVA Nyse

Equities

BBVA

US05946K1016

Real-time Estimate Cboe BZX Other stock markets 10:07:09 10/05/2024 pm IST			5-day change	1st Jan Change
10.38 ^USD	+1.61%		-1.61%	+14.38%

06:30pm	European Equities Close Higher in Friday Trading; UK GDP Grows in Q1 Following Two Quarters of Declines	MT
05:32pm	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	MT

Strengths

Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company's share price in relation to its net book value makes it look relatively cheap.
This company will be of major interest to investors in search of a high dividend stock.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
Over the past four months, analysts' average price target has been revised upwards significantly.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Banks

	1st Jan change	Capi.	ESG Refinitiv
BBVA	+14.38%	59.13B	-
BANK OF AMERICA CORPORATION	+14.30%	299B	C+
INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED	+18.59%	249B	C+
WELLS FARGO & COMPANY	+25.53%	214B	C
CHINA CONSTRUCTION BANK CORPORATION	+21.29%	172B	B-
BANK OF CHINA LIMITED	+25.50%	169B	B-
HSBC HOLDINGS PLC	+9.52%	160B	C+
ROYAL BANK OF CANADA	+5.66%	146B	B-
HDFC BANK LIMITED	-15.88%	132B	B-
COMMONWEALTH BANK OF AUSTRALIA	+5.13%	129B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes